BR112017019480A2 - dosagem unitária de composição vitamínica ampliável, e, método para tratar uma deficiência de vitamina lipossolúvel. - Google Patents
dosagem unitária de composição vitamínica ampliável, e, método para tratar uma deficiência de vitamina lipossolúvel.Info
- Publication number
- BR112017019480A2 BR112017019480A2 BR112017019480-5A BR112017019480A BR112017019480A2 BR 112017019480 A2 BR112017019480 A2 BR 112017019480A2 BR 112017019480 A BR112017019480 A BR 112017019480A BR 112017019480 A2 BR112017019480 A2 BR 112017019480A2
- Authority
- BR
- Brazil
- Prior art keywords
- vitamin
- unit dosage
- fat
- expandable
- treating
- Prior art date
Links
- 229940088594 vitamin Drugs 0.000 title abstract 4
- 229930003231 vitamin Natural products 0.000 title abstract 4
- 235000013343 vitamin Nutrition 0.000 title abstract 4
- 239000011782 vitamin Substances 0.000 title abstract 4
- 208000000412 Avitaminosis Diseases 0.000 title abstract 3
- 206010021135 Hypovitaminosis Diseases 0.000 title abstract 3
- 208000030401 vitamin deficiency disease Diseases 0.000 title abstract 3
- 150000003722 vitamin derivatives Chemical class 0.000 title abstract 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract 1
- 229930003448 Vitamin K Natural products 0.000 abstract 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 235000019155 vitamin A Nutrition 0.000 abstract 1
- 239000011719 vitamin A Substances 0.000 abstract 1
- 235000019168 vitamin K Nutrition 0.000 abstract 1
- 239000011712 vitamin K Substances 0.000 abstract 1
- 150000003721 vitamin K derivatives Chemical class 0.000 abstract 1
- 229940045997 vitamin a Drugs 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
- 229940046010 vitamin k Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
é provida aqui uma dosagem unitária de composição vitamínica ampliável adaptada para tratar uma deficiência de vitamina lipossolúvel em um indivíduo, a dosagem unitária consistindo essencialmente em vitamina d, vitamina e, vitamina k e vitamina a, em que a dosagem unitária é substancialmente livre de vitaminas adicionais e em que a dosagem unitária é ampliável com base no peso, na idade e na condição de um indivíduo sem induzir efeitos tóxicos. também são providos métodos para tratar uma deficiência de vitamina lipossolúvel em um indivíduo em necessidade da mesma, administrando ao indivíduo uma quantidade eficaz de uma dosagem unitária como aqui descrito.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562134818P | 2015-03-18 | 2015-03-18 | |
| US62/134818 | 2015-03-18 | ||
| PCT/US2016/023229 WO2016149655A1 (en) | 2015-03-18 | 2016-03-18 | Scalable vitamin composition unit dosage for the treatment of fat-soluble vitamin deficiencies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112017019480A2 true BR112017019480A2 (pt) | 2018-05-22 |
Family
ID=56919527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112017019480-5A BR112017019480A2 (pt) | 2015-03-18 | 2016-03-18 | dosagem unitária de composição vitamínica ampliável, e, método para tratar uma deficiência de vitamina lipossolúvel. |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US10688107B2 (pt) |
| EP (1) | EP3270883B1 (pt) |
| BR (1) | BR112017019480A2 (pt) |
| WO (1) | WO2016149655A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11229230B2 (en) | 2016-10-24 | 2022-01-25 | Callion Pharma, Llc | Antioxidant-enriched multivitamin composition and methods of use |
| IT201800005508A1 (it) * | 2018-05-18 | 2019-11-18 | Kit per uso come integratore alimentare nel trattamento delle carenze di vitamine e/o minerali in ambito pediatrico. | |
| US11273123B2 (en) | 2018-07-18 | 2022-03-15 | USpharma Ltd | Chewable pharmaceutical dosage forms |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR046773A1 (es) * | 2003-12-23 | 2005-12-21 | Novartis Ag | Formulaciones farmaceuticas de bisfosfonatos |
| US20050209315A1 (en) * | 2004-03-20 | 2005-09-22 | Papas Andreas M | Bioavailable nutritional supplement and method of treatment of malabsorption |
| US20080070845A1 (en) * | 2006-09-18 | 2008-03-20 | Thompson Ronald V | Method and formulations to concurrently reduce fracture risk and insure appropriate fat-soluble vitamin supplementation when using Orlistat, an oral lipase inhibitor |
| WO2008070308A2 (en) * | 2006-10-24 | 2008-06-12 | Thompson Md Ronald J | Method and composition of a carminative herb or natural supplement to decrease the adverse effects of orlistat, an oral lipase inhibitor, and a method with formulations to concurrently reduce fracture risk and insure appropriate fatsoluble vitamin supplementation when using orlistat, an oral lipase inhibitor, and a method o |
| CA2829180C (en) | 2010-03-05 | 2019-01-15 | Newagriculture, Inc. | Leaf protein-lipid-soluble material complexes |
| US20140017337A1 (en) * | 2012-07-11 | 2014-01-16 | Paul Amoruso | Therapeutic methods |
-
2016
- 2016-03-18 US US15/558,622 patent/US10688107B2/en active Active
- 2016-03-18 EP EP16765854.1A patent/EP3270883B1/en active Active
- 2016-03-18 BR BR112017019480-5A patent/BR112017019480A2/pt not_active Application Discontinuation
- 2016-03-18 WO PCT/US2016/023229 patent/WO2016149655A1/en active Application Filing
-
2020
- 2020-04-30 US US16/862,770 patent/US20200253989A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016149655A1 (en) | 2016-09-22 |
| EP3270883B1 (en) | 2024-04-24 |
| US20180177804A1 (en) | 2018-06-28 |
| EP3270883A1 (en) | 2018-01-24 |
| EP3270883C0 (en) | 2024-04-24 |
| US20200253989A1 (en) | 2020-08-13 |
| EP3270883A4 (en) | 2018-07-25 |
| US10688107B2 (en) | 2020-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019000268A1 (es) | Composición de cannabis. | |
| BR112019001794A2 (pt) | composição de cannabis | |
| BR112016002465A2 (pt) | terapia da combinação para o tratamento de câncer | |
| BR112018008965A8 (pt) | terapia de reposição de plasminogênio para deficiência de plasminogênio | |
| BR112019008431A2 (pt) | aplicação de (s)-norcetamina e sal da mesma como fármaco | |
| BR112015023349A2 (pt) | composto, composição farmacêutica, e, método de tratamento de uma doença, condição de saúde ou distúrbio | |
| BR112017025339A2 (pt) | composições nutricionais contendo um nível elevado de inositol e usos das mesmas | |
| BR112013000027A2 (pt) | tratamento de distúrbios cognitivos | |
| CL2015000039A1 (es) | Derivados estra-1,3,5(10),16-tetraeno-3-sustituidos, preparaciones farmacéuticas que los comprenden y su uso en la preparación de medicamentos para tratar la endometriosis. | |
| BR112016025876A8 (pt) | composição, processos para preparar uma microcápsula e uma forma de dosagem unitária, forma de dosagem unitária, microcápsula, produto, uso de uma composição, e, método para tratar uma condição associada à vitamina k1 ou k2 | |
| BR112017006113A8 (pt) | usos de auristatina, composições farmacêuticas, formas de dosagem para o tratamento de câncer e kits. | |
| BR112018003745A2 (pt) | composições que compreendem um composto de urolitina | |
| BR112016027043A8 (pt) | combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer | |
| BR112021019262A2 (pt) | Uso de ciclo-his-pro (chp) para prevenir, atenuar ou tratar fibrose | |
| UY37729A (es) | NUEVOS COMPUESTOS QUE INHIBEN LA ACTIVIDAD DE Nav1.7 | |
| BR112017007138A2 (pt) | composto, medicamento, métodos para reduzir proteína 4 de ligação ao retinol e para a profilaxia ou o tratamento de degeneração macular e/ou uma doença, e, uso de um composto. | |
| BR112017007774A2 (pt) | Um ou uma combinação dos fitocanabinoides canabidiol (cbd); canabidivarina (cbdv); e tetra- hidrocanabivarina (thcv), combinação dos fitocanabinoides, formulação farmacêutica, e, método para tratamento de um indivíduo que sofre de distrofia muscular de duchenne (dmd). | |
| BR112018000841A2 (pt) | agente estimulante de receptor 5-hidroxitriptamina1b para uso como um promotor de auto-renovação e/ou diferenciação de células satélites | |
| BR112017019480A2 (pt) | dosagem unitária de composição vitamínica ampliável, e, método para tratar uma deficiência de vitamina lipossolúvel. | |
| BR112018069727A2 (pt) | métodos de tratamento com vitamina d | |
| AR102308A1 (es) | Composición farmacéutica para usar en el tratamiento o prevención de deficiencias de vitaminas y minerales en pacientes sometidos a cirugía de bypass gástrico | |
| ECSP19000167A (es) | Métodos y composiciones para el tratamiento de la hipercalciuria y la nefrolitiasis | |
| BR112014025973A2 (pt) | preparação e método para prevenir e tratar a osteoporose e fraturas ósseas | |
| BR112017016042A2 (pt) | cápsula compósita, e, método para preparar uma cápsula compósita | |
| AR101673A1 (es) | Composición para el tratamiento de neuropatías y del dolor neuropático |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |